BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

e vs leupeptin

Mechanistic comparison of e 64c and leupeptin based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

2
Shared Targets
17%
Jaccard Similarity
15%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

e 64c
Evidence Score
PubMed Studies
View full profile →
leupeptin
Evidence Score
0
PubMed Studies
View full profile →

Target Overlap

e and leupeptin share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.167 means 17% of the combined target set is bound by both compounds. The IDF-weighted score of 0.151 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do e and leupeptin have in common?
e and leupeptin share 2 molecular targets with a Jaccard similarity of 17%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can e and leupeptin be combined?
e and leupeptin share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: e or leupeptin?
Both e and leupeptin have substantial PubMed research. View their individual profiles for full evidence scores.

Related Comparisons

Similar to e

e vs calpeptin2 targetse vs aloxistatin2 targetse vs e3 targetse vs mg2 targets

Similar to leupeptin

leupeptin vs e5 targetsleupeptin vs calpeptin3 targetsleupeptin vs aloxistatin3 targetsleupeptin vs cyano3 targetsleupeptin vs telaprevir4 targets
View full e profile →View full leupeptin profile →Browse all substances →